ALMOTRIPTAN MALATE PDF

In addition, it is expected that almotriptan malate (AXERT®) is generally Trial to Evaluate the Efficacy of Almotriptan Malate (AXERT®) Milligram. Almotriptan is a headache medicine that narrows blood vessels around the brain. Almotriptan also reduces substances in the body that can. Almotriptan is a triptan drug for the treatment of migraine headaches. Almotriptan Malate, Tablet, coated, mg/1, Oral, Patriot Pharmaceuticals,

Major Almotriotan is a serotonin reuptake inhibitor. Etoperidone The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Etoperidone. Clothiapine The risk or severity of adverse effects can be increased ma,ate Almotriptan is combined with Clothiapine. However, the risk may be increased when combined with other serotonergic agents, especially at times of antidepressant dose increases.

Droperidol Droperidol may increase the central nervous system depressant CNS depressant activities of Almotriptan.

Major Linezolid is an antibiotic that is also a reversible, non-selective inhibitor of MAO and should not be administered with serotonin-receptor agonists. Hexafluronium The malqte or severity of adverse effects can be increased when Almotriptan is combined with Hexafluronium. Almotriptan is contraindicated in patients with known hypersensitivity to almotriptan or any of its ingredients.

Etorphine The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Etorphine. Major Based on the mechanism of action of trazodone and the potential for serotonin almotripttan, caution is advised when trazodone is coadministered with other drugs that may affect these neurotransmitter systems, including the serotonin-receptor agonists “triptans”.

The efficacy and tolerability of almotriptan has been studied in numerous randomised, control-led trials totaling more than adults with either moderate or severe attacks of migraine.

Axert (almotriptan malate) dose, indications, adverse effects, interactions from

Cilazapril The risk or severity of hypertension can be increased when Almotriptan is combined with Cilazapril. If serotonin syndrome occurs, all serotonergic drugs should be discontinued and appropriate medical treatment should be initiated. Ibutilide Ibutilide may decrease the excretion rate of Almotriptan which could result in a higher serum level.

Chromium gluconate Almotriptan may decrease the excretion rate of Chromium gluconate which could result in a higher serum level. Discontinue remifentanil if serotonin syndrome is suspected. Ethchlorvynol The risk or severity of adverse effects can be increased when Kalate is combined with Almotriptan. Brentuximab vedotin The metabolism of Almotriptan can be decreased when combined with Brentuximab vedotin.

Neither of these changes was considered clinically significant and did not require dose adjustment.

Amisulpride The risk or severity of adverse effects can be increased when Almotriptan is combined with Amisulpride. Decamethonium The risk or severity of adverse effects can be increased when Almotriptan is combined with Decamethonium.

Cefepime Cefepime may decrease the excretion rate of Almotriptan which could result in a higher serum level. MAO-A is responsible for the formation of the indoleacetic acid metabolite, whereas cytochrome P CYP3A4 and CYP2D6 catalyzes the hydroxylation of the pyrrolidine ring to an intermediate that is further oxidized by aldehyde dehydrogenase to the gamma-amino-butyric acid derivative; almptriptan metabolites are inactive.

Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Almotriptan. Serotonin syndrome, in its most severe form, can resemble neuroleptic malignant syndrome. Ecopipam The risk or severity of adverse effects can be increased when Almotriptan is combined with Ecopipam.

Almotriptan

Rare, but serious adverse cardiac effects, mqlate heart attacks, life-threatening disturbances of cardiac rhythm, and death have been reported within a few hours of receiving 5-HT1 agonists. Serious CNS reactions, such as serotonin syndrome, have been reported maltae the concurrent use of linezolid, which is structurally similar to tedizolid, and psychiatric medications that enhance central serotonergic activity; therefore, caution is warranted with concomitant use of other agents with serotonergic activity.

Acenocoumarol The metabolism of Acenocoumarol can be decreased when combined with Almotriptan. Furazolidone The metabolism of Almotriptan can be decreased when combined with Furazolidone. Etoricoxib Etoricoxib may decrease the excretion rate of Almotriptan which could result in a higher serum level.

If only partial relief is attained or it returns quickly, a second dose may be taken 2 hours after the first. Hydroxyethyl Starch Almotriptan may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level. This interaction could lead to ‘serotonin syndrome’ presenting as agitation, restlessness, aggressive behavior, insomnia, poor concentration, headache, paresthesia, incoordination, worsening of obsessive thoughts or compulsive behavior, nausea, abdominal cramps, diarrhea, palpitations, or chills.

Cyamemazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Cyamemazine. Detomidine The risk or severity of adverse effects can be increased when Almotriptan is combined with Detomidine.

Fexofenadine The risk or severity of adverse effects can be increased when Almotriptan is combined with Fexofenadine. Alclofenac Alclofenac may decrease the excretion rate of Almotriptan which could result in a higher serum level.

Almotriptan malate | C21H31N3O7S – PubChem

Fimasartan The risk allmotriptan severity of hypertension can be increased when Almotriptan is combined with Fimasartan. Dolasetron The risk or severity of serotonin syndrome can be increased when Dolasetron is combined with Almotriptan. Edivoxetine The risk or severity of adverse effects can be increased when Almotriptan is combined with Edivoxetine.

Dotarizine The risk or severity of adverse effects can be increased when Almotriptan is combined with Dotarizine.